1-4 of 4
Li Zhiming
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety Results of TQB3909 in Patients (Pts) with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Keshu Zhou, Hongyun Xing, Qingliang Teng, Wuping Li, Yafei Wang, Feng Zhu, Zhengming Jin, Li Zhiming, Guifang Ouyang, Fang Xu, Shihua Huang, Jianyong Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4627.
https://doi.org/10.1182/blood-2024-202814
Published: 2024
Journal Articles

Disease Characteristics and Treatment Outcomes with HLX01: A Real-World Study in Patients with B-Cell Non-Hodgkin Lymphoma in China

Jun Ma, Li Zhiming, Wei Xu, Yao Liu, Weili Zhao, Zhihua Yao, Kaiyang Ding, Yudan Wu, Hong Liu, Wenyu Li, Yirong Jiang, Li'e Lin, Zhigang Peng, Zhimin Zhai
Journal: Blood
Blood (2022) 140 (Supplement 1): 12130–12132.
https://doi.org/10.1182/blood-2022-166137
Published: 2022
Journal Articles

P-Gemox Regimen(Pegaspargase, Gemcitabine, oxaliplatin) for Extranodal Natural Killer Cell Lymphoma: 10 Years' Real-World Clinical Experience from China

Gao Yan, Hui-qiang Huang, MD PhD, Wang Xiaoxiao, Bai Bing, Pengfei Li, Hui Zhou, Zhi-gang Peng, Xiao-yan Ke, Kai-yang Ding, Yu Yang, MD, Sha-dong Min, Yue-rong Shuang, Li Zhiming, Cai Qingqing, Bingzong Li, MDPhD, Wenqi Jiang
Journal: Blood
Blood (2018)
https://doi.org/10.1182/blood-2018-99-116551
Published: 2018
Journal Articles

Chidamide ,Oral Subtype-Selective Histone Deacetylase Inhibitor (HDACI) Monotherapy Was Effective on the Patients with Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma

Gao Yan, Hui-qiang Huang, Pengfei Li, Bai Bing, Wang Xiaoxiao, Rong Qixiang, Li Zhiming, Cai Qingqing, Wenqi Jiang
Journal: Blood
Blood (2017) 130 (Supplement 1): 2797.
https://doi.org/10.1182/blood.V130.Suppl_1.2797.2797
Published: 2017